UroGen Pharma Ltd. (URGN) Shareholders’ equity 2016–2025
UroGen Pharma Ltd. (URGN) shareholders’ equity at each fiscal year-end, per SEC filings.
-$105.5MFY2025 · since FY2016: $16.3M → -$105.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.5M | -1098.2% |
| FY2024 | -$8.8M | +86.5% |
| FY2023 | -$65.2M | +27.0% |
| FY2022 | -$89.4M | -1162.2% |
| FY2021 | $8.4M | -91.3% |
| FY2020 | $96.4M | -46.6% |
| FY2019 | $180.3M | +100.1% |
| FY2018 | $90.1M | +31.5% |
| FY2017 | $68.5M | +320.2% |
| FY2016 | $16.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice